ECM
ELDN icon

ExodusPoint Capital Management’s Eledon Pharmaceuticals ELDN Stock Holding History

ExodusPoint Capital Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,733
Closed -$74K – 1589
2025
Q1 		$74K Buy
+21,733
New +$89.4K ﹤0.01% 1357
2021
Q2 		– Sell
-17,773
Closed -$190K – 2470
2021
Q1 		$190K Buy
+17,773
New +$268K ﹤0.01% 1884

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

ExodusPoint Capital Management's ELDN Position: Q2 2025 in Review

ExodusPoint Capital Management sold out of Eledon Pharmaceuticals (ELDN) in Q2 2025, closing a stake of 21,733 shares — an estimated $74K sold.

ExodusPoint Capital Management first reported a position in ELDN in Q1 2021 and held it in 2 quarters. The position peaked at $190K in Q1 2021. 85 funds tracked by Wall St. Rank hold ELDN as of Q2 2025.

  • ExodusPoint Capital Management reported no remaining Eledon Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 21,733 Eledon Pharmaceuticals shares in Q2 2025, an estimated $74K.
  • ExodusPoint Capital Management first reported a position in Eledon Pharmaceuticals in Q1 2021 and held it in 2 quarters.
  • ExodusPoint Capital Management's Eledon Pharmaceuticals position peaked at $190K in Q1 2021.
  • 85 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2025.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.